The iShares MSCI World ETF (URTH) enters a defining stretch this week, with three of its largest holdings—Alphabet, Microsoft, and Apple—scheduled to report earnings within a 48-hour window. The fund closed Friday at $195.27, a hair’s breadth below its 52-week high of $195.79, and has gained roughly 5% since the start of the year. But with technology commanding over 26% of the portfolio, the next few days will determine whether that momentum holds or falters.
Alphabet kicks things off on Wednesday, April 29, after the bell. Analysts are looking for earnings per share of $2.68 on revenue of around $107 billion. Notably, not a single sell-side analyst has a sell rating on the stock. The company has signaled capital expenditure plans for fiscal 2026 between $175 billion and $185 billion—nearly double last year’s spending—as it races to build out AI infrastructure.
Microsoft, carrying a 3.44% portfolio weight, reports the same day. Its cloud division Azure posted 39% growth last quarter, while overall revenue climbed 17%. TD Cowen recently trimmed its price target to $540, citing GPU infrastructure bottlenecks that could constrain near-term expansion.
Apple follows on Thursday, April 30. Analysts project second-quarter revenue growth of 13% to 16%, buoyed by a surprisingly strong performance in China, where iPhone shipments jumped 20% even as the broader market contracted by 4%.
A $1.75 Trillion Wild Card
While earnings dominate the near-term narrative, a longer-term structural shift looms on the horizon. SpaceX filed a confidential registration statement with the SEC on April 1, 2026, confirmed by Bloomberg, CNBC, Reuters, and the Wall Street Journal. The company is targeting a valuation of $1.75 trillion, which would dwarf Saudi Aramco’s previous IPO record and instantly place SpaceX among the ten most valuable publicly traded companies globally.
For URTH holders, an eventual index inclusion would be transformative. The MSCI World weights by free-float market capitalization, meaning a SpaceX listing would trigger billions in index-driven inflows, further tilt the portfolio toward U.S. exposure, and introduce a heavy dose of aerospace and software. The ripple effects would be felt across the fund’s sector allocations and could shift the weightings of existing mega-caps.
Banks Deliver, Pharma Faces Headwinds
The financial sector—the fund’s second-largest at 16.17%—has already turned in a strong earnings season. Morgan Stanley surpassed $20 billion in quarterly revenue for the first time, with profit climbing 29% to $5.57 billion. JPMorgan Chase posted $50.54 billion in revenue, up 10% year-over-year, while its equity trading desk notched a record $5.15 billion. Goldman Sachs also reported record trading results. These numbers underpin FactSet’s forecast for 12.5% S&P 500 earnings growth in the first quarter of 2026.
The picture is less rosy in healthcare, which accounts for roughly 9.5% of the portfolio. New U.S. import tariffs on pharmaceutical products are set to take effect at the end of July 2026, with rates as high as 100% for manufacturers without U.S. pricing agreements. Producers in the EU, Japan, South Korea, and Switzerland face a 15% levy, while British manufacturers would see 10%. Analysts estimate the measures could slow global growth and add roughly 0.5 percentage points to inflation.
Should investors sell immediately? Or is it worth buying MSCI World ETF?
Tesla’s Mixed Bag and a Technical Warning
Tesla’s first-quarter results sent contradictory signals. Adjusted earnings per share of 41 cents beat expectations by 4 cents, but revenue of $22.39 billion fell just short of the $22.64 billion consensus. The stock initially rose about 4% after hours, only to give back those gains when the company announced it would boost 2026 capital expenditure by $5 billion above previous guidance.
The energy storage business added to the disappointment, with deployed capacity falling 38% to 8.8 GWh against analyst estimates of 12 to 14 GWh. Tesla has underperformed all major tech peers year-to-date, sitting 14% in the red at the time of its report. That drags on the technology segment, which now represents nearly 28% of the ETF.
Adding to the technical picture, the fund’s relative strength index sits at 94.6—deep in overbought territory. That doesn’t guarantee a pullback, but it suggests the rally may be stretched.
Fee Competition Heats Up
The cost war among MSCI World ETF providers is intensifying. Invesco slashed the expense ratio on its competing fund from 0.19% to 0.05% on April 1, following similar moves by UBS and BNP Paribas. URTH’s total expense ratio of 0.24% now sits 19 basis points above the cheapest rival. Morningstar gives the fund a Bronze rating but flags the cost disadvantage.
BlackRock counters by pointing to URTH’s tracking difference of just 0.02%—a measure of how closely the fund follows its benchmark after expenses. That argument appears to resonate with institutional investors: the Royal Bank of Canada increased its position by 17.5% to roughly 2 million shares. Over the past three months, the fund has attracted net inflows of approximately $770 million.
Index Reform on the Horizon
Starting in May 2026, MSCI will overhaul its methodology for calculating free float, introducing a three-tier classification system. The resulting portfolio rebalancing could meaningfully shift the weightings of mega-cap holdings like Nvidia—far more than a typical quarterly adjustment would. For a fund that tracks market-cap-weighted indices, these methodological changes can have outsized effects on sector and single-stock exposure.
The next ex-dividend date for URTH is June 15, 2026, following a year in which dividends grew by more than 20%. How high the fund’s price climbs between now and then will largely depend on the numbers Alphabet, Microsoft, and Apple deliver this week.
Ad
MSCI World ETF Stock: Buy or Sell?! New MSCI World ETF Analysis from April 25 delivers the answer:
The latest MSCI World ETF figures speak for themselves: Urgent action needed for MSCI World ETF investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from April 25.
MSCI World ETF: Buy or sell? Read more here...









